Pancreatic Cancer Research

ResearcherSheng Jing HospitalActive in the last 2 years

Qian Dong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9810-1368; OpenAlex author ID A5101665484. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2014: 2 papers · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 5

  1. Domestication and feedback: bidirectional hijacking in pancreatic ductal adenocarcinoma microenvironment. Last author DOI 10.3389/fimmu.2025.1585858↗
  2. Cbl-b predicts postoperative survival in patients with resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.18714↗
  3. MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.11001↗
  4. Serum calcium level used as a prognostic predictor in patients with resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.clinre.2014.01.012↗
  5. Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study. Co-author DOI 10.1186/1477-7819-12-171↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuxi Qiao · 1 shared paper, 2025 · strength 0.33
  2. Yong Zhang · 1 shared paper, 2025 · strength 0.33
  3. Xiujuan Qu · 4 shared papers, 2014–2017 · strength 0.21
  4. Xiaofang Che · 2 shared papers, 2016–2017 · strength 0.12
  5. Ce Li · 2 shared papers, 2016–2017 · strength 0.12
  6. Zhi Li · 2 shared papers, 2014–2017 · strength 0.11
  7. Yao Zhang · 2 shared papers, 2014 · strength 0.09
  8. Wei Jing · 2 shared papers, 2014 · strength 0.09
  9. Xianghong Yang · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.